Sierra Oncology (SRRA) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free SRRA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Sierra Oncology Short Interest DataCurrent Short Volume571,500 sharesPrevious Short Volume797,900 sharesChange Vs. Previous Month-28.37%Dollar Volume Sold Short$31.38 millionShort Interest Ratio / Days to Cover0.9Last Record DateJune 15, 2022Outstanding Shares24,419,000 sharesPercentage of Shares Shorted2.34%Today's Trading Volume0 sharesAverage Trading Volume931,731 sharesToday's Volume Vs. Average0% Short Selling Sierra Oncology ? Sign up to receive the latest short interest report for Sierra Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSRRA Short Interest Over TimeSRRA Days to Cover Over TimeSRRA Percentage of Float Shorted Over Time Ad InvestorPlaceElon Musk’s Next Move Will Disrupt AI ForeverA revolutionary venture that is set to get rolled out by May 16. One well-connected Silicon Valley VC has uncovered a way for anybody to claim a stake in "Elon Musk's AI 2.0" with as little as $100.Get all the information here. Sierra Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/2022571,500 shares $31.38 million -28.4%N/A0.9 $54.90 5/31/2022797,900 shares $43.71 million -10.4%N/A1.4 $54.78 5/15/2022890,100 shares $48.61 million -11.9%N/A1.5 $54.61 4/30/20221,010,000 shares $55.06 million -55.9%N/A1.7 $54.51 4/15/20222,290,000 shares $125.38 million +55.8%18.7%1.5 $54.75 3/31/20221,470,000 shares $47.11 million +21.5%15.5%1.2 $32.05 Get the Latest News and Ratings for SRRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sierra Oncology and its competitors with MarketBeat's FREE daily newsletter. 3/15/20221,210,000 shares $38.89 million +11.0%11.9%1.1 $32.14 2/28/20221,090,000 shares $33.69 million +26.4%13.3%1 $30.91 2/15/2022862,600 shares $28.03 million -26.3%10.5%0.8 $32.50 1/31/20221,170,000 shares $31.58 million +1,821.2%22.2%1.1 $26.99 1/15/202260,900 shares $1.28 million -78.2%0.9%0.1 $21.02 12/31/2021278,700 shares $6.06 million +366.1%4.9%6.4 $21.74 12/15/202159,800 shares $1.35 million +26.7%1.1%1.3 $22.50 11/30/202147,200 shares $1.10 million +0.9%1.1%1.1 $23.29 11/15/202146,800 shares $1.05 million -27.2%1.1%1.1 $22.41 10/29/202164,300 shares $1.29 million -15.5%1.5%1.9 $20.00 10/15/202176,100 shares $1.62 million -2.4%1.7%1.3 $21.30 9/30/202178,000 shares $1.71 million +201.2%1.8%1.3 $21.92 9/15/202125,900 shares $530,950.00 -11.9%0.6%0.5 $20.50 8/31/202129,400 shares $597,408.00 -2.0%0.7%0.6 $20.32 8/13/202130,000 shares $594,000.00 -34.1%0.7%0.7 $19.80 7/30/202145,500 shares $864,500.00 -38.8%0.9%1.1 $19.00 7/15/202174,400 shares $1.52 million -25.9%1.2%5.6 $20.37 6/30/2021100,400 shares $1.95 million +311.5%1.6%7.8 $19.47 6/15/202124,400 shares $443,104.00 No Change0.4%2.5 $18.16 5/28/202124,400 shares $436,577.00 -11.9%0.4%0.9 $17.89 5/14/202127,700 shares $486,412.00 -12.6%0.5%1 $17.56 4/30/202131,700 shares $569,332.00 +8.9%0.5%1 $17.96 4/15/202129,100 shares $537,186.00 +20.3%0.5%0.9 $18.46 3/31/202124,200 shares $411,400.00 +236.1%0.4%0.6 $17.00 3/15/20217,200 shares $119,160.00 -20.0%0.1%0.2 $16.55 2/26/20219,000 shares $130,275.00 +83.7%0.2%0.3 $14.48 2/12/20214,900 shares $72,275.00 +32.4%0.1%0.2 $14.75 1/29/20213,700 shares $55,537.00 -36.2%0.1%0.1 $15.01 1/15/20215,800 shares $92,510.00 +38.1%0.1%0.2 $15.95 12/31/20204,200 shares $67,158.00 -16.0%0.1%0.1 $15.99 12/15/20205,000 shares $76,450.00 -35.9%0.1%0.2 $15.29 11/30/20207,800 shares $110,682.00 -42.7%0.2%0.3 $14.19 11/15/202013,600 shares $202,096.00 +7.9%0.3%0.6 $14.86 10/30/202012,600 shares $172,242.00 +18.9%0.3%0.5 $13.67Guard Against the Coming Financial Upheaval (Ad)America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.You can stream it for free right here. SRRA Short Interest - Frequently Asked Questions What is Sierra Oncology's current short interest? Short interest is the volume of Sierra Oncology shares that have been sold short but have not yet been closed out or covered. As of June 15th, investors have sold 571,500 shares of SRRA short. Learn More on Sierra Oncology's current short interest. What is a good short interest ratio for Sierra Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SRRA shares currently have a short interest ratio of 1.0. Learn More on Sierra Oncology's short interest ratio. Is Sierra Oncology's short interest increasing or decreasing? Sierra Oncology saw a drop in short interest in June. As of June 15th, there was short interest totaling 571,500 shares, a drop of 28.4% from the previous total of 797,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Sierra Oncology's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Sierra Oncology: Ligand Pharmaceuticals Incorporated (4.43%), ANI Pharmaceuticals, Inc. (1.09%), Ironwood Pharmaceuticals, Inc. (13.04%), Arcus Biosciences, Inc. (16.36%), Gyre Therapeutics, Inc. (0.54%), Prothena Co. plc (12.55%), Belite Bio, Inc (0.06%), Kiniksa Pharmaceuticals, Ltd. (5.51%), Spyre Therapeutics, Inc. (12.81%), Pacira BioSciences, Inc. (7.73%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.58 billion), Occidental Petroleum Co. ($3.23 billion), Lucid Group, Inc. ($2.31 billion), Coinbase Global, Inc. ($1.73 billion), Snowflake Inc. ($1.71 billion), Chesapeake Energy Co. ($1.66 billion), Rivian Automotive, Inc. ($1.63 billion), Williams-Sonoma, Inc. ($1.51 billion), Lumen Technologies, Inc. ($1.40 billion), and Diamondback Energy, Inc. ($1.37 billion). View all of the most shorted stocks. What does it mean to sell short Sierra Oncology stock? Short selling SRRA is an investing strategy that aims to generate trading profit from Sierra Oncology as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Sierra Oncology? A short squeeze for Sierra Oncology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SRRA, which in turn drives the price of the stock up even further. How often is Sierra Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SRRA, twice per month. The most recent reporting period available is June, 15 2022. More Short Interest Resources from MarketBeat Related Companies: LGND Short Squeeze ANIP Short Squeeze IRWD Short Squeeze RCUS Short Squeeze GYRE Short Squeeze PRTA Short Squeeze BLTE Short Squeeze KNSA Short Squeeze SYRE Short Squeeze PCRX Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SRRA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals